Diclofenac Formulations for Actinic Keratosis
Approved Formulations and Indications
- The FDA-approved diclofenac topical formulation for skin conditions is 3% diclofenac sodium in 2.5% hyaluronic acid gel, which is indicated for actinic keratosis (AK) 1
- Standard application is twice daily for 60-90 days as a field-based or lesion-directed treatment 1
- Diclofenac gel causes less intense local skin reactions than 5-fluorouracil (5-FU) or imiquimod 5% cream, making it more tolerable but potentially less effective 1
Efficacy for Actinic Keratosis
- Complete clearance rates with diclofenac 3% gel range from 19-50% after 90 days of treatment 1, 2
- In comparative studies, diclofenac 3% gel showed 32% complete clearance versus 55.4% for 5-FU 0.5% in 10% salicylic acid 3
- Extending treatment from 90 to 180 days provides only an additional 5% complete clearance without significant changes in adverse effects 1
Special Considerations by Treatment Site
- For actinic keratosis on the face and scalp: Apply twice daily for 60-90 days 1
- For forearm and hands: May require prolonged treatment due to thicker skin or hindrance to penetration by keratin in thicker AKs 4
- For below the knee: Use with caution due to potential healing issues, especially in elderly patients; consider less frequent application 4
Adverse Effects and Monitoring
- For patients with poor healing sites such as the lower leg, treatment should be undertaken with caution and may need supervision 3